OneSource Specialty Pharma Ltd Share Price
As on 13 June 2026 at 02:17 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-8.43%
Over 6 Months
-0.13%
Over 1 Year
-19.50%
Over 3 Years
None%
OneSource Specialty Pharma Ltd Summary
Close ₹1,651.40
Open ₹1,681.20
High ₹1,697.30
Low ₹1,634.90
Volume 1,00,140
Net Turnover (in Cr) ₹16.69
52Wk High ₹2,248
52Wk Low ₹1,057
52Wk High / Low
1,057
2,248
OneSource Specialty Pharma Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹18,932.61
EPS (TTM) 2.32
Book Value (BV) 519.01
Div. Yield -
P/E (TTM) 891.46
Price/Book Value 3.18
Delivery % 41.20 %
Face Value 1
Key Ratios
PE Ratio 1,034.35
PB Ratio 3.38
EV to Sales 15.94
PEG Ratio -10.17
ROA 0.28
ROE 3.22
Debt-Equity 0.24
Net Profit Margin 10.05
Operating Profit Margin 29.71
OneSource Specialty Pharma Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,462.33 | 176.14 | 41.41 | 131.85 | 22.39 |
| Total Expenses | 1,418.55 | 425.90 | 312.63 | 231.76 | 142.96 |
| Profit Before Tax | -67.07 | -365.70 | -415.64 | -99.91 | -120.56 |
| Profit After Tax | -17.28 | -365.70 | -415.64 | -99.80 | -120.83 |
| Operating Profit After Depreciation | 210.10 | -160.31 | -223.68 | -53.41 | -104.75 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 6,275.56 | 1,007.88 | 1,504.57 | 1,653.09 | 985.51 |
| Total Non Current Assets | 6,464.06 | 1,132.23 | 1,780.40 | 1,931.26 | 1,159.09 |
| Total Current Assets | 1,086.18 | 176.38 | 228.40 | 511.10 | 98.72 |
| Total Assets | 7,550.24 | 1,308.61 | 2,008.81 | 2,442.36 | 1,257.81 |
| Total Shareholder's Fund | 5,880.58 | 395.71 | 785.45 | 1,012.48 | 776.02 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -67.85 | -107.21 | -162.88 | -415.89 | -117.58 |
| Net Cash Used In Investing Activities | -201.06 | 510.55 | -67.72 | -691.60 | -207.37 |
| Net Cash Used In Financing Activities | 412.01 | -390.54 | 118.32 | 1,161.96 | 380.96 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,317.27 | 176.14 | 41.42 | 137.99 | 22.39 |
| Total Expenses | 1,226.48 | 425.14 | 312.56 | 367.73 | 143.63 |
| Profit Before Tax | -21.45 | -364.93 | -429.55 | -229.74 | -121.24 |
| Profit After Tax | 20 | -364.93 | -429.55 | -229.74 | -121.24 |
| Operating Profit After Depreciation | 252.44 | -159.58 | -223.60 | -161.72 | -105.44 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 3,345.81 | 1,007.88 | 1,504.57 | 1,603.10 | 937.21 |
| Total Non Current Assets | 6,366.58 | 1,132.16 | 1,780.23 | 1,933.33 | 1,163.80 |
| Total Current Assets | 1,023.88 | 176.42 | 228.21 | 511.67 | 98.37 |
| Total Assets | 7,390.46 | 1,308.58 | 2,008.44 | 2,445 | 1,262.17 |
| Total Shareholder's Fund | 5,920.10 | 397.74 | 786.71 | 1,015.51 | 778.55 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | -47.28 | -108.99 | -164.70 | -419.66 | -114.88 |
| Net Cash Used In Investing Activities | -300.04 | 505.99 | -65.68 | -684.54 | -210.34 |
| Net Cash Used In Financing Activities | 417.22 | -384.22 | 118.32 | 1,158.75 | 380.97 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 428.22 | 290.34 | 375.76 | 327.27 | 425.95 |
| Total Expenses | 336.29 | 273.02 | 269.27 | 238.79 | 244.13 |
| Profit Before Tax | -0.29 | -93.01 | 5.74 | -4.40 | 82.81 |
| Profit After Tax | 4.60 | -88.70 | 10.49 | -0.19 | 98.50 |
| Operating Profit after Depreciation | 94.02 | 21.95 | 109.53 | 93.75 | 184.71 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 418.96 | 290.22 | 375.19 | 321.01 | 477.41 |
| Total Expenses | 344.25 | 277.38 | 273.60 | 241.14 | 241.15 |
| Profit Before Tax | 21.48 | -62.19 | 37.11 | 24.82 | 174.19 |
| Profit After Tax | 21.48 | -62.19 | 37.10 | 24.82 | 174.19 |
| Operating Profit after Depreciation | 76.80 | 17.46 | 104.63 | 85.13 | 240.17 |
OneSource Specialty Pharma Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 1,625.10
S2 1,598.80
S3 1,562.70
Pivot 1,661.20
R1 1,687.50
R2 1,723.60
R3 1,749.90
Moving Average
20 SMA 1,801.05
50 SMA 1,691.78
100 SMA 1,529.43
200 SMA 1,653.30
OneSource Specialty Pharma Ltd Corporate Actions
No available data
OneSource Specialty Pharma Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
OneSource Specialty Pharma Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Motilal Oswal ELSS Tax Saver Fund | 4.78% |
| Motilal Oswal Large and Midcap Fund | 4.05% |
| Mirae Asset Healthcare Fund | 3.26% |
| Motilal Oswal Flexi Cap Fund | 3.06% |
| 360 ONE Focused Fund | 1.78% |
OneSource Specialty Pharma Ltd News
OneSource Specialty Pharma allots 3,150 equity shares under ESOP
13 May 2026, 01:52 pm
OneSource Specialty Pharma to discuss results
On 13 May 2026
08 May 2026, 11:36 am
OneSources' CDMO client receives Health Canada approval for semaglutide injection
04 May 2026, 10:17 am
OneSource's partner Dr. Reddy's receives Health Canada approval for Semaglutide Injection
29 Apr 2026, 09:50 am
ONESOURCE's partner receives USFDA tentative approval for Semaglutide Injection
21 Apr 2026, 09:18 am
OneSource Specialty Pharma Ltd Stock Analysis
- Annual revenue for OneSource Specialty Pharma Ltd increased by 647.84% to ₹1,317.27 crore in FY 2025 from ₹176.14 crore in FY 2024.
- Annual Net Profit for OneSource Specialty Pharma Ltd decreased by 105.48% to ₹20 crore in FY 2025 from ₹-364.93 crore in FY 2024.
- Promoter Shareholding in OneSource Specialty Pharma Ltd increased by 1.85% in the most recent quarter, from 29.93% in December 2025 to 30.48% in March 2026.
- OneSource Specialty Pharma Ltd delivered a 1-year return of -19.50% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- OneSource Specialty Pharma Ltd share price moved down by 0.22% from its previous close of INR ₹1,651.40. The latest OneSource Specialty Pharma Ltd share price is INR ₹1,647.70.
- OneSource Specialty Pharma Ltd share price today has been at a low of 1,617.80 and a high of 1,670. Over the past 52 weeks, the OneSource Specialty Pharma Ltd share price has seen a low of 1,057 and a high of 2,248.
FAQ’s
What is the share price of OneSource Specialty Pharma Ltd today?
OneSource Specialty Pharma Ltd share price as on 12 Jun 2026 is ₹ 1647.7
What is the Market Cap of OneSource Specialty Pharma Ltd?
The market cap of OneSource Specialty Pharma Ltd stock is ₹18,932.61 Cr.
What is the PE Ratio of OneSource Specialty Pharma Ltd?
The Price to Earnings (P/E) Ratio of OneSource Specialty Pharma Ltd is 1,034.35
What is the PB Ratio of OneSource Specialty Pharma Ltd?
The Price to Book (P/B) Ratio of OneSource Specialty Pharma Ltd is 3.38
What is the 52 week high of OneSource Specialty Pharma Ltd Share Price?
The 52 week high of OneSource Specialty Pharma Ltd share price stands at ₹2,248
What is the 52 week low of OneSource Specialty Pharma Ltd Share Price?
The 52 week low of OneSource Specialty Pharma Ltd share price stands at ₹1,057
How can I buy shares of OneSource Specialty Pharma Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of OneSource Specialty Pharma Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
